Bismuth 213-labeled anti-CD45 radioimmunoconjugate to condition dogs for nonmyeloablative allogeneic marrow grafts.

MLA

Sandmaier, Brenda M., et al. “Bismuth 213-Labeled Anti-CD45 Radioimmunoconjugate to Condition Dogs for Nonmyeloablative Allogeneic Marrow Grafts.” Blood, vol. 100, no. 1, July 2002, pp. 318–26. EBSCOhost, https://doi.org/10.1182/blood-2001-12-0322.

APA

Sandmaier, B. M., Bethge, W. A., Wilbur, D. S., Hamlin, D. K., Santos, E. B., Brechbiel, M. W., Fisher, D. R., & Storb, R. (2002). Bismuth 213-labeled anti-CD45 radioimmunoconjugate to condition dogs for nonmyeloablative allogeneic marrow grafts. Blood, 100(1), 318–326. https://doi.org/10.1182/blood-2001-12-0322

Chicago

Sandmaier, Brenda M, Wolfgang A Bethge, D Scott Wilbur, Donald K Hamlin, Erlinda B Santos, Martin W Brechbiel, Darrell R Fisher, and Rainer Storb. 2002. “Bismuth 213-Labeled Anti-CD45 Radioimmunoconjugate to Condition Dogs for Nonmyeloablative Allogeneic Marrow Grafts.” Blood 100 (1): 318–26. doi:10.1182/blood-2001-12-0322.